The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected ...

A new evidence review says that coffee and tea consumption are linked to a lower risk of cancers of the mouth, throat, and ...

Missed out on giant S&P 500 winners this year like Nvidia and Eli Lilly? Don't worry: Analysts think you'll get another shot ...

Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...

The Japanese company urged Biden to reflect on the steps it has taken to address national-security concerns. One crew member was in intensive care after engine problems and smoke in the cabin and ...

A source close to the toy industry has leaked a copy of Santa’s perks list for Wisconsin politicians, business leaders and ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...